Seminars in Perinatology
Volume 31, Issue 4 , Pages 250-253 , August 2007

Venous Thromboembolism in the Neonatal Period

  • Diana S. Beardsley, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Diana S. Beardsley, MD, PhD, Department of Pediatrics, Yale Women and Children’s Center for Blood Disorders, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208021, New Haven, CT 06520-3209.

References 

  1. Chalmers EA. Epidemiology of venous thromboembolism in neonates and children. Thromb Res. 2006;118:3–12
  2. Andrew M, Paes B, Johnston M. Am J Pedriatr Hematol Oncol. 1990;12:95–104
  3. Schmidt B, Andrew M. Neonatal thrombosis: report of a Canadian and international registry. Pediatrics. 1995;96:939–943
  4. Nowak-Gottl U, von Kries R, Gobel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed. 1997;76:163–167
  5. van Ommen CH, Heijboer H, Buller HR, et al. Venous thromboembolism in childhood: a prospective two year registry in the Netherlands. J Pediatr. 2001;139:676–681
  6. Nowak-Gottl U, Kosch A, Schlegel N. Neonatal thromboembolism. Semin Thromb Haemost. 2003;29:229–234
  7. Tormene D, Simioni P, Prandoni P, Franz F, et al. The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. Blood. 2002;100:2403–2405
  8. Miletich JP, Prescott SM, White R, et al. Inherited pedispositions to thrombosis. Cell. 1993;72:477–480
  9. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost. 1997;78:297–301
  10. Koeleman BP, Reitsm PH, Allaart CF, et al. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood. 1994;84:1031–1035
  11. Pipe SW, Schmaier AH, Nichols WC, et al. Neonatal purpura fulminans in association with factor V R506Q mutation. J Pediatr. 1996;128:706–709
  12. van Boven HH, Reitsma PH, Rosendaal FR, et al. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency. Thromb Haemost. 1996;75:417–421
  13. Zoller B, Berntsdotter A, Garcia de Frutos P, et al. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1995;85:3518–3523
  14. Manco-Johnson MJ, Grabowski EF, Hallgreen M, et al. Laboratory testing for thrombophilia in pediatric patients (On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the International Society of Thrombosis and Haemostasis (ISTH)). Thromb Haemost. 2002;88:155–156
  15. Massicotte MP, Dix D, Monagle P, et al. Central venous catheter-related thrombosis in children: analysis of the Canadian registry of venous thromboembolic compolications. J Pediatr. 1998;133:770–776
  16. Male C, Chait P, Andrew M, et al. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood. 2003;101:4273–4278
  17. Butler-O’Hara M, Buzzard CJ, Reubens L, et al. A randomized trial comparing long-term and short-term use of umbilical venous catheters in premature infants with birth weights of less than 1251 grams. Pediatrics. 2006;118:e25–e35
  18. Monagle P, Chan A, Massicotte P, et al. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:6455–6875
  19. Manco-Johnson MJ. How I treat venous thrombosis in children. Blood. 2006;107:21–29
  20. Thornburg C, Pipe S. Neonatal thromboembolic emergencies. Sem Fetal & Neonatal Med. 2006;11:198–206
  21. Risch L, Fischer J, Herklotz R, et al. Heparin induced thrombocytopenia in paediatrics: clinical characteristics, therapy, and outcomes. Intensive Care Med. 2004;30:1615–1624
  22. Goldenberg NA, Durham JD, Knapp-Clevenger R, et al. A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children. Blood. 2007;110:45–53
  23. Kuhle S, Koloshuk B, Marzinotto V, et al. A cross-sectional study evaluating postthrombotic syndrome in children. Thromb Res. 2003;111:227–233
  24. Journeycake J, Manco-Johnson MJ. Thrombosis during infancy: what we know and what we do not know. Hematol Oncol Clin North Am. 2004;18:1314–1338
  25. Goldenberg NA. Long-term outcomes of venous thrombisis in children. Curr Opin Hematol. 2005;12:370–376
  26. Monagle P, Adams M, Mahoney M, et al. Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thromboembolic registry. Pediatr Res. 2000;47:763–776
  27. van Ommen CH, Heijboer H, van den Dool EJ, et al. Pedaitric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J Thromb Haemost. 2003;1:2516–2522
  28. Manco-Johnson MJ. Postthrombotic syndrome in children. Acta Hematol. 2006;115:207–213
  29. Goldenberg N, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med. 2004;351:1081–1088
  30. Hausler M, Hubner D, Delhaas T, et al. Long term complications of inferior vena cava thrombosis. Arch Dis Child. 2001;85:228–233

PII: S0146-0005(07)00078-X

doi: 10.1053/j.semperi.2007.07.011

Seminars in Perinatology
Volume 31, Issue 4 , Pages 250-253 , August 2007

Article Tools